Antibodies of HNRNPAB


2 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
HNRNPABProduct_ID: PA5-27549
Lot_ID: TL2692997
Source: Thermo Fisher
Target Name: HNRNPAB-human		 HNRNPAB-HEPG2-PA5-27549.png<br>Caption: Western blot following shRNA against HNRNPAB in HepG2 whole cell lysate using HNRNPAB specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different shRNA against HNRNPAB. HNRNPAB protein appears as the green arrow, Tubulin serves as a control and appears in red arrow.
 ThermoFisher_PA5-27549_TL2692997_HNRNPAB.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the HNRNPAB specific antibody, PA5-27549. Lane 1 is 2.5% of five million whole cell lysate input. Lanes 2 and 3 are 50% of IP enrichment from five million whole cell lysate using normal IgG antibody and the HNRNPAB-specific antibody, PA5-27549. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.
 HNRNPAB-K562-PA5-27549.png<br>Caption: Western blot following shRNA against HNRNPAB in K562 whole cell lysate using HNRNPAB specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different shRNA against HNRNPAB. HNRNPAB protein appears as the green arrow, Tubulin serves as a control and appears in red arrow.
HNRNPABProduct_ID: GTX101852
Lot_ID: 39645
Source: GeneTex
Target Name: HNRNPAB-human		 GeneTex_GTX101852_39645_HNRNPAB.png<br>Caption: IP-WB characterization of HNRNPAB specific antibody in K562 cell line . Lane 1 is 2.5% of five million K562 whole cell lysate Input, lane 2 is 2.5% of supernatant after immunoprecipitation and Lane 3 is 50% of IP enrichment using rabbit polyclonal hnRNPA/B antibody. This antibody did not meet our primary validation criteria using our standard IP protocol in the indicated cell type.